|
ZNF552 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62492241884138E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62447832963153E-12 |
| Normal-vs-Stage2 |
1.61549995603139E-09 |
| Normal-vs-Stage3 |
5.31019672678212E-13 |
| Normal-vs-Stage4 |
3.14193115968919E-14 |
| Stage1-vs-Stage2 |
5.377000E-01 |
| Stage1-vs-Stage3 |
3.753600E-01 |
| Stage1-vs-Stage4 |
3.821500E-03 |
| Stage2-vs-Stage3 |
1.648410E-01 |
| Stage2-vs-Stage4 |
4.717800E-03 |
| Stage3-vs-Stage4 |
1.391610E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62614366416847E-12 |
| Normal-vs-AfricanAmerican |
5.64440050254689E-10 |
| Normal-vs-Asian |
6.425600E-04 |
| Caucasian-vs-AfricanAmerican |
4.413200E-01 |
| Caucasian-vs-Asian |
4.776200E-01 |
| AfricanAmerican-vs-Asian |
6.893600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
7.04569957932222E-10 |
| Male-vs-Female |
1.418080E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.14872564185953E-12 |
| Normal-vs-Extreme_Weight |
1.62447832963153E-12 |
| Normal-vs-Obese |
1.9720003407997E-10 |
| Normal-vs-Extreme_Obese |
5.652400E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.048400E-02 |
| Normal_Weight-vs-Obese |
9.423200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.383800E-01 |
| Extreme_Weight-vs-Obese |
1.209220E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.985000E-01 |
| Obese-vs-Extreme_Obese |
6.550600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.94790019856373E-10 |
| Normal-vs-Age(41-60Yrs) |
2.09721129351692E-13 |
| Normal-vs-Age(61-80Yrs) |
5.32796029517613E-13 |
| Normal-vs-Age(81-100Yrs) |
3.03809977175717E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.914400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.657400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.364800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.275000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.280300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.093900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62447832963153E-12 |
| Normal-VS-Type2 PRCC |
1.33226762955019E-15 |
| Normal-VS-KIRP CIMP |
7.93130006115916E-10 |
| Normal-VS-Unclassified PRCC |
5.17500486907352E-11 |
| Type1 PRCC-VS-Type2 PRCC |
8.959200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.242000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.792790E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.702400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.656000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.010090E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.4718009557273E-14 |
| Normal-vs-N1 |
6.58639809358874E-11 |
| Normal-vs-N2 |
4.11449999999647E-05 |
| N0-vs-N1 |
8.139600E-01 |
| N0-vs-N2 |
2.139200E-01 |
| N1-vs-N2 |
3.183200E-01 |
|
|
